Bruce C. Cozadd, Chairman & CEO at Jazz Pharmaceuticals plc (JAZZ), sold 1,500 shares at $122.31 ($183K) on 2025-02-03, disclosed to the SEC on 2025-02-05.
Scheduled sale ($183k) by Chairman & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| JAZZ | SELL | 2026-07-06 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-06-03 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-05-05 | $1.2M | — | Filing → |